In this Clinical Grand Round Live Dr. Nicole Beurkens talks with Dr. Frank Ervolino about the abundance of information available through the BiomeFx stool test. Dr. Ervolino holds degrees in Naturopathic Medicine and Acupuncture from Bastyr University at Mind Body Jupiter Medical Center. He has also been a writer and media specialist for the natural medicine field, working as the senior editor of Better Nutrition Magazine and an expert for nutritionally syndicated Healthy Talk Radio and TV. For the past 25 years, Dr. Ervolino has also worked as a professional supplement formulator and has a private practice in Stuart, Florida.
Dr. Sivamani, MD, MS, AP is a board-certified dermatologist and Ayurvedic practitioner who merges modern research and science with a personalized approach to each patient. He practices at his medical and surgical dermatology clinic at Pacific Skin Institute and his integrative research, aesthetics, and wellness clinic at Zen Dermatology.
Dr. Raja serves as the Director of Clinical Research at Integrative Skin Science and Research, the Director of Clinical Research in the Department of Dermatology at the University of California, Davis, as well as the Co-Director of the Microbiome Research Initiative at the California State University, Sacramento.
The gut microbiome affects the skin’s health and can modulate hormones.
The presentation covers various factors impacting acne, such as dietary choices (e.g., soft drinks, sweetened teas) and hormonal imbalances.
Probiotics, particularly spore-based ones, show promise in improving acne symptoms and hormonal pathways.
Kiran Krishnan discusses the relationship between a dysfunctional gut and brain toxicity, leading to mood and aging disorders. The discussion covers topics like gut dysbiosis, inflammation, and the role of the gut-brain axis in various health issues. New research and practical tools to support patients dealing with gut and brain-related problems are highlighted. Understanding the patient’s microbiome resilience through testing is crucial to assess diversity, pathobiome, short-chain fatty acid production, and other functionalities. Q&A session is included at the end to address audience questions.